09/25/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 9/25/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Genetrack SARS-CoV-2 Molecular Assay. The Genetrack SARS-CoV-2 Molecular Assay is authorized for use with anterior nasal swab specimens self-collected at home using the Vo’ COVID-19 Test Home Collection Kit by individuals suspected of COVID-19 when home collection is determined to be appropriate by their healthcare provider. (PDF)
.png)
No hay comentarios:
Publicar un comentario